To evaluate the effect of NKG2D–NKG2D-L interactions between cells of the immune system (such as NK and CD8+ T cells) and HSPCs, we conducted in vitro NKG2D–blocking assays with BM samples from patients with FA and HDs. The gene discussed is KLRK1; the disease is Friedreich ataxia.